161 related articles for article (PubMed ID: 31859463)
1. Phosphocyclocreatine is the dominant form of cyclocreatine in control and creatine transporter deficiency patient fibroblasts.
Gorshkov K; Wang AQ; Sun W; Fisher E; Frigeni M; Singleton M; Thorne N; Class B; Huang W; Longo N; Do MT; Ottinger EA; Xu X; Zheng W
Pharmacol Res Perspect; 2019 Dec; 7(6):e00525. PubMed ID: 31859463
[TBL] [Abstract][Full Text] [Related]
2. Cyclocreatine treatment ameliorates the cognitive, autistic and epileptic phenotype in a mouse model of Creatine Transporter Deficiency.
Cacciante F; Gennaro M; Sagona G; Mazziotti R; Lupori L; Cerri E; Putignano E; Butt M; Do MT; McKew JC; Alessandrì MG; Battini R; Cioni G; Pizzorusso T; Baroncelli L
Sci Rep; 2020 Oct; 10(1):18361. PubMed ID: 33110151
[TBL] [Abstract][Full Text] [Related]
3. Facile High-Performance Liquid Chromatography Mass Spectrometry Method for Analysis of Cyclocreatine and Phosphocyclocreatine in Complex Mixtures of Amino Acids.
Tao D; Leister W; Huang W; Alimardanov A; LeClair CA
J Agric Food Chem; 2019 Jun; 67(25):7190-7196. PubMed ID: 31194545
[TBL] [Abstract][Full Text] [Related]
4. Functional assessment of creatine transporter in control and X-linked SLC6A8-deficient fibroblasts.
Joncquel-Chevalier Curt M; Bout MA; Fontaine M; Kim I; Huet G; Bekri S; Morin G; Moortgat S; Moerman A; Cuisset JM; Cheillan D; Vamecq J
Mol Genet Metab; 2018 Apr; 123(4):463-471. PubMed ID: 29478817
[TBL] [Abstract][Full Text] [Related]
5. Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency.
Kurosawa Y; Degrauw TJ; Lindquist DM; Blanco VM; Pyne-Geithman GJ; Daikoku T; Chambers JB; Benoit SC; Clark JF
J Clin Invest; 2012 Aug; 122(8):2837-46. PubMed ID: 22751104
[TBL] [Abstract][Full Text] [Related]
6. Treatment of X-linked creatine transporter (SLC6A8) deficiency: systematic review of the literature and three new cases.
Dunbar M; Jaggumantri S; Sargent M; Stockler-Ipsiroglu S; van Karnebeek CD
Mol Genet Metab; 2014 Aug; 112(4):259-74. PubMed ID: 24953403
[TBL] [Abstract][Full Text] [Related]
7. Dodecyl creatine ester therapy: from promise to reality.
Mabondzo A; van de Kamp J; Mercimek-Andrews S
Cell Mol Life Sci; 2024 Apr; 81(1):186. PubMed ID: 38632116
[TBL] [Abstract][Full Text] [Related]
8. Dodecyl creatine ester and lipid nanocapsule: a double strategy for the treatment of creatine transporter deficiency.
Trotier-Faurion A; Passirani C; Béjaud J; Dézard S; Valayannopoulos V; Taran F; de Lonlay P; Benoit JP; Mabondzo A
Nanomedicine (Lond); 2015 Jan; 10(2):185-91. PubMed ID: 24559037
[TBL] [Abstract][Full Text] [Related]
9. The Role of Preclinical Models in Creatine Transporter Deficiency: Neurobiological Mechanisms, Biomarkers and Therapeutic Development.
Ghirardini E; Calugi F; Sagona G; Di Vetta F; Palma M; Battini R; Cioni G; Pizzorusso T; Baroncelli L
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440297
[TBL] [Abstract][Full Text] [Related]
10. Cognitive deficits and increases in creatine precursors in a brain-specific knockout of the creatine transporter gene Slc6a8.
Udobi KC; Kokenge AN; Hautman ER; Ullio G; Coene J; Williams MT; Vorhees CV; Mabondzo A; Skelton MR
Genes Brain Behav; 2018 Jul; 17(6):e12461. PubMed ID: 29384270
[TBL] [Abstract][Full Text] [Related]
11. [Simultaneous determination of guanidinoacetate, creatine and creatinine by liquid chromatography-tandem mass spectrometry: a diagnostic tool for creatine deficiency syndromes in body fluids and a perspective use on cultured fibroblasts].
Van Noolen L; Monneret D; Ducros V; Corne C; Lunardi J; Faure P
Ann Biol Clin (Paris); 2013; 71(4):429-37. PubMed ID: 23906570
[TBL] [Abstract][Full Text] [Related]
12. Cerebral creatine deficiency: Black cat in the coal cellar.
Cherian A; Divya KP
Acta Neurol Belg; 2021 Dec; 121(6):1859-1861. PubMed ID: 32681499
[No Abstract] [Full Text] [Related]
13. Use of an animal model of disease for toxicology enables identification of a juvenile no observed adverse effect level for cyclocreatine in creatine transporter deficiency.
Do MT; Cavagnaro J; Butt M; Terse PS; McKew JC
Regul Toxicol Pharmacol; 2021 Jul; 123():104939. PubMed ID: 33961952
[TBL] [Abstract][Full Text] [Related]
14. Creatine Transporter Deficiency in Two Brothers with Autism Spectrum Disorder.
Aydin HI
Indian Pediatr; 2018 Jan; 55(1):67-68. PubMed ID: 29396939
[TBL] [Abstract][Full Text] [Related]
15. Cyclocreatine Transport by SLC6A8, the Creatine Transporter, in HEK293 Cells, a Human Blood-Brain Barrier Model Cell, and CCDSs Patient-Derived Fibroblasts.
Uemura T; Ito S; Masuda T; Shimbo H; Goto T; Osaka H; Wada T; Couraud PO; Ohtsuki S
Pharm Res; 2020 Mar; 37(3):61. PubMed ID: 32124083
[TBL] [Abstract][Full Text] [Related]
16. Creatine Transporter Deficiency: Screening of Males with Neurodevelopmental Disorders and Neurocognitive Characterization of a Case.
Thurm A; Himelstein D; DʼSouza P; Rennert O; Jiang S; Olatunji D; Longo N; Pasquali M; Swedo S; Salomons GS; Carrillo N
J Dev Behav Pediatr; 2016 May; 37(4):322-6. PubMed ID: 27096572
[TBL] [Abstract][Full Text] [Related]
17. RNA sequencing of creatine transporter (SLC6A8) deficient fibroblasts reveals impairment of the extracellular matrix.
Nota B; Ndika JD; van de Kamp JM; Kanhai WA; van Dooren SJ; van de Wiel MA; Pals G; Salomons GS
Hum Mutat; 2014 Sep; 35(9):1128-35. PubMed ID: 24962355
[TBL] [Abstract][Full Text] [Related]
18. Rescue by 4-phenylbutyrate of several misfolded creatine transporter-1 variants linked to the creatine transporter deficiency syndrome.
El-Kasaby A; Kasture A; Koban F; Hotka M; Asjad HMM; Kubista H; Freissmuth M; Sucic S
Neuropharmacology; 2019 Dec; 161():107572. PubMed ID: 30885608
[TBL] [Abstract][Full Text] [Related]
19. Is low serum creatine kinase a nonspecific screening marker for creatine deficiency syndromes?
Mercimek-Mahmutoglu S; Al-Thihli K; Roland E
Mol Genet Metab; 2012 Jun; 106(2):251-2. PubMed ID: 22551696
[No Abstract] [Full Text] [Related]
20. Creatine transport and pathological changes in creatine transporter deficient mice.
Wawro AM; Gajera CR; Baker SA; Nirschl JJ; Vogel H; Montine TJ
J Inherit Metab Dis; 2021 Jul; 44(4):939-948. PubMed ID: 33389772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
